In a context marked by political transformations and public health issues, the CEO of Advamed congratulated the new president of the United States, Donald Trump, emphasizing the importance of adequate support for public policies to foster innovation in the medical technology sector. This statement appears as a call to action, aimed at ensuring that the regulatory framework evolves in step with technological advances and the growing needs of patients.

The CEO of Advamed, Scott Whitaker, expressed his congratulations to Donald Trump following his re-election and stressed the need for support for public policies in order to encourage innovation in the sector medical technology. In his statement, Whitaker highlighted the importance of the ecosystem medtech for the American healthcare system, emphasizing that the regulatory environment must evolve alongside technological advances to meet the needs of patients. He also expressed his anticipation of collaborating with the new administration on issues critical to businesses in the sector.

Advamed CEO congratulates Trump

Scott Whitaker, Chairman and CEO of Advamed, extended his congratulations to the President-elect Donald Trump after his electoral success. In emphasizing the need for public support for innovation, Whitaker emphasizes the fundamental role the medtech sector plays in the U.S. healthcare system. The influence of this industry, often described as the backbone of healthcare, should not be underestimated.

importance of support for public policies

In his statement, Whitaker emphasized that for themedical innovation prosperous, foster an environment of public policies favorable is essential. He called on new administrations to work closely with the sector to adapt regulations and guidelines that support technological advances. Keeping pace with innovations and customer needs patients is at the heart of this mission.

transformation of the medical sector

The scale of the changes brought about by medical technologies was also highlighted by Whitaker. These innovations have profoundly transformed patient care, allowing for more precise diagnoses and more effective treatments. In a context where the demand for medical solutions is evolving rapidly, companies must feel supported by policies that encourage research and development.